Stewart Altman, wheelchair-bound, fights for cure as gene therapy shows promise. May 13, 2011— -- For 26 years, doctors could not piece together the medical puzzle of Stewart Altman's symptoms -- ...
Patients in a Phase I/II clinical trial conducted by UMass Chan Medical School of a dual vector gene therapy for GM2 gangliosidosis, which includes Tay-Sachs and Sandhoff diseases, exhibited a ...
Hosted on MSN
Scientists lay foundation for potential gene-editing therapy for late-onset Tay-Sachs disease
Scientists at the National Institutes of Health (NIH) have successfully reduced the severity of late-onset Tay-Sachs (LOTS) disease in human cell cultures and a mouse model by using a novel ...
Patients in a Phase I/II clinical trial conducted by UMass Chan Medical School of a dual vector gene therapy for GM2 gangliosidosis, which includes Tay-Sachs and Sandhoff diseases, exhibited a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback